152 related articles for article (PubMed ID: 15326385)
1. Detecting and diagnosing ampullary neoplasms.
Wang LF; Hingorani SR; Tuveson DA
Cancer Biol Ther; 2004 Jul; 3(7):657-9. PubMed ID: 15326385
[No Abstract] [Full Text] [Related]
2. Gene expression profiling identifies markers of ampullary adenocarcinoma.
Van Heek NT; Maitra A; Koopmann J; Fedarko N; Jain A; Rahman A; Iacobuzio-Donahue CA; Adsay V; Ashfaq R; Yeo CJ; Cameron JL; Offerhaus JA; Hruban RH; Berg KD; Goggins M
Cancer Biol Ther; 2004 Jul; 3(7):651-6. PubMed ID: 15136764
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA expression profiles associated with pancreatic adenocarcinoma and ampullary adenocarcinoma.
Schultz NA; Werner J; Willenbrock H; Roslind A; Giese N; Horn T; Wøjdemann M; Johansen JS
Mod Pathol; 2012 Dec; 25(12):1609-22. PubMed ID: 22878649
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2.
Chu PG; Schwarz RE; Lau SK; Yen Y; Weiss LM
Am J Surg Pathol; 2005 Mar; 29(3):359-67. PubMed ID: 15725805
[TBL] [Abstract][Full Text] [Related]
5. Coexistent ampullary squamous cell carcinoma with adenocarcinoma of the pancreatic duct.
Pathak GS; Deshmukh SD; Yavalkar PA; Ashturkar AV
Saudi J Gastroenterol; 2011; 17(6):411-3. PubMed ID: 22064341
[TBL] [Abstract][Full Text] [Related]
6. Ep-CAM expression in pancreatic and ampullary carcinomas: frequency and prognostic relevance.
Fong D; Steurer M; Obrist P; Barbieri V; Margreiter R; Amberger A; Laimer K; Gastl G; Tzankov A; Spizzo G
J Clin Pathol; 2008 Jan; 61(1):31-5. PubMed ID: 16775119
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic challenge: intraductal neoplasms of the pancreatobiliary system.
Tajiri T; Tate G; Matsumoto K; Hoshino H; Iwamura T; Kodaira Y; Takahashi K; Ohike N; Kunimura T; Mitsuya T; Morohoshi T
Pathol Res Pract; 2012 Nov; 208(11):691-6. PubMed ID: 23057996
[TBL] [Abstract][Full Text] [Related]
8. Expression of p16 protein and cyclin D1 in periampullary carcinomas.
Tuncer E; Türk NS; Arici S; Düzcan SE; Demirkan NC
Turk Patoloji Derg; 2011 Jan; 27(1):17-22. PubMed ID: 21469422
[TBL] [Abstract][Full Text] [Related]
9. Huge Periampullary Mass: Where Is the Origin?
Kim SB; Lee DS; Choi JH
Gastroenterology; 2020 Sep; 159(3):e13-e15. PubMed ID: 32142782
[No Abstract] [Full Text] [Related]
10. Phenotypic characterization and clinical outcome in ampullary adenocarcinoma.
Asano E; Okano K; Oshima M; Kagawa S; Kushida Y; Munekage M; Hanazaki K; Watanabe J; Takada Y; Ikemoto T; Shimada M; Suzuki Y;
J Surg Oncol; 2016 Jul; 114(1):119-27. PubMed ID: 27132476
[TBL] [Abstract][Full Text] [Related]
11. [Report from the 37th annual meeting of the "European Pancreatic Club." Graz, Austria, 6-8 July 2005].
Barbu ST; Zărnescu NO; Andrén-Sandberg T
Chirurgia (Bucur); 2006; 101(2):209-11. PubMed ID: 16752690
[No Abstract] [Full Text] [Related]
12. Expression and prognostic significance of 14-3-3sigma and ERM family protein expression in periampullary neoplasms.
Hustinx SR; Fukushima N; Zahurak ML; Riall TS; Maitra A; Brosens L; Cameron JL; Yeo CJ; Offerhaus GJ; Hruban RH; Goggins M
Cancer Biol Ther; 2005 May; 4(5):596-601. PubMed ID: 15908786
[TBL] [Abstract][Full Text] [Related]
13. Intra-pancreatic Distal Bile Duct Carcinoma is Morphologically, Genetically, and Clinically Distinct from Pancreatic Ductal Adenocarcinoma.
Deshpande V; Konstantinidis IT; Castillo CF; Hezel AF; Haigis KM; Ting DT; Bardeesy N; Goyal L; Zhu AX; Warshaw AL; Lillemoe KD; Ferrone CR
J Gastrointest Surg; 2016 May; 20(5):953-9. PubMed ID: 26956004
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis.
Moore PS; Orlandini S; Zamboni G; Capelli P; Rigaud G; Falconi M; Bassi C; Lemoine NR; Scarpa A
Br J Cancer; 2001 Jan; 84(2):253-62. PubMed ID: 11161385
[TBL] [Abstract][Full Text] [Related]
15. Ampullary and periampullary tumors: translational efforts to meet a challenge in diagnosis and treatment. Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011.
Kang SP; Saif MW
JOP; 2011 Mar; 12(2):123-5. PubMed ID: 21386636
[TBL] [Abstract][Full Text] [Related]
16. Tumor-specific Expression of Insulin-like Growth Factor II mRNA-binding Protein 3 Independently Predicts Worse Survival of Patients With Adenocarcinoma of the Ampulla of Vater.
Kim HG; Park MS; Sung JY; Kim YW; Kim HS; Na K
Anticancer Res; 2019 Sep; 39(9):4947-4955. PubMed ID: 31519600
[TBL] [Abstract][Full Text] [Related]
17. HER-2/Neu overexpression is a rare event in peri-ampullary cancer: assessment using the HercepTest.
Aloysius MM; Lobo DN; Rowlands BJ; Madhusudan S; Ilyas M; Zaitoun AM
Histopathology; 2009 Aug; 55(2):236-7. PubMed ID: 19694833
[No Abstract] [Full Text] [Related]
18. Significant overexpression of SPARC/osteonectin mRNA in pancreatic cancer compared to cancer of the papilla of Vater.
Prenzel KL; Warnecke-Eberz U; Xi H; Brabender J; Baldus SE; Bollschweiler E; Gutschow CA; Hölscher AH; Schneider PM
Oncol Rep; 2006 May; 15(5):1397-401. PubMed ID: 16596217
[TBL] [Abstract][Full Text] [Related]
19. Expression of gastric mucin MUC5AC and gastric transcription factor SOX2 in ampulla of vater adenocarcinoma: comparison between expression patterns and histologic subtypes.
Sanada Y; Yoshida K; Konishi K; Oeda M; Ohara M; Tsutani Y
Oncol Rep; 2006 May; 15(5):1157-61. PubMed ID: 16596179
[TBL] [Abstract][Full Text] [Related]
20. K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma.
Wilentz RE; Chung CH; Sturm PD; Musler A; Sohn TA; Offerhaus GJ; Yeo CJ; Hruban RH; Slebos RJ
Cancer; 1998 Jan; 82(1):96-103. PubMed ID: 9428484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]